Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Glatzer, Markus; Rittmeyer, Achim; Müller, Joachim; Opitz, Isabelle; Papachristofilou, Alexandros; Psallidas, Ioannis; Früh, Martin; Born, Diana; Putora, Paul Martin (2017). Treatment of limited disease small cell lung cancer: the multidisciplinary team. European Respiratory Journal, 50(2):1700422.

Rosell, Rafael; Dafni, Urania; Felip, Enriqueta; Curioni-Fontecedro, Alessandra; Gautschi, Oliver; Peters, Solange; Massutí, Bartomeu; Palmero, Ramon; Aix, Santiago Ponce; Carcereny, Enric; Früh, Martin; Pless, Miklos; Popat, Sanjay; Kotsakis, Athanasios; Cuffe, Sinead; Bidoli, Paolo; Favaretto, Adolfo; Froesch, Patrizia; Reguart, Noemí; Puente, Javier; Coate, Linda; Barlesi, Fabrice; Rauch, Daniel; Thomas, Michael; Camps, Carlos; Gómez-Codina, Jose; Majem, Margarita; Porta, Rut; Shah, Riyaz; Hanrahan, Emer; et al (2017). Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial. Lancet Respiratory Medicine, 5(5):435-444.

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Hasan Ali, Omar; Diem, Stefan; Markert, Eva; Jochum, Wolfram; Kerl, Katrin; French, Lars E; Speiser, Daniel E; Früh, Martin; Flatz, Lukas (2016). Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer. OncoImmunology, 5(11):e1231292.

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Gautschi, Oliver; Milia, Julie; Cabarrou, Bastien; Bluthgen, Marie-Virginia; Besse, Benjamin; Smit, Egbert F; Wolf, Juergen; Peters, Solange; Früh, Martin; Koeberle, Dieter; Oulkhouir, Youssouf; Schuler, Martin; Curioni-Fontecedro, Alessandra; Huret, Benjamin; Kerjouan, Mallorie; Michels, Sebastian; Pall, Georg; Rothschild, Sacha; Schmid-Bindert, Gerald; Scheffler, Matthias; Veillon, Rémi; Wannesson, Luciano; Diebold, Joachim; Zalcman, Gérard; Filleron, Thomas; Mazières, Julien (2015). Targeted therapy for patients with BRAF-mutant lung cancer: results from the european EURAF cohort. Journal of Thoracic Oncology, 10(10):1451-1457.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Jürgens, Verena; Ess, Silvia; Phuleria, Harish C; Früh, Martin; Schwenkglenks, Matthias; Frick, Harald; Cerny, Thomas; Vounatsou, Penelope (2013). Bayesian spatio-temporal modelling of tobacco-related cancer mortality in Switzerland. Geospatial Health, 7(2):219-236.

Jürgens, Verena; Ess, Silvia; Phuleria, Harish C; Früh, Martin; Schwenkglenks, Matthias; Frick, Harald; Cerny, Thomas; Vounatsou, Penelope (2013). Tobacco-related cancer mortality: projections for different geographical regions in Switzerland. Swiss Medical Weekly, 143:w13771.

This list was generated on Wed Feb 21 20:21:28 2018 CET.